Primary subcutaneous nocardial infection in a SLE patient.
A patient with systemic lupus erythematosus (SLE) developed primary subcutaneous nocardiosis during steroid and cyclophosphamide therapy for diffuse proliferative glomerulonephritis. In spite of local process the patient manifested signs of general deterioration mimicking SLE exacerbation. The diagnosis was made by bacteriologic examination of the material obtained by CT guided aspiration. Surgical drainage and systemic treatment with trimethoprim/sulphamethoxazole (TMT/SMZ) 960 mg twice/d led to a clinical recovery and enabled the continuation of the steroid and cytotoxic regimen.
Balbir-Gurman
A
A
The B Shine Department of Rheumatology, Rambam Medical Center, Haifa, Israel.
Schapira
D
D
Nahir
A M
AM
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D009617:Nocardia Infections / Q000150:complications* / Q000276:immunology; D009894:Opportunistic Infections / Q000150:complications; D011241:Prednisone / Q000009:adverse effects; D012871:Skin Diseases / Q000276:immunology / Q000382:microbiology*
D000893:Anti-Inflammatory Agents; D011241:Prednisone